Preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of NK cells against leukemia. J Biol Chem. 2015;290:22474.

科学

致力于研究对抗癌症、感染性疾病和自身免疫疾病的创新免疫疗法

首页 > 科学 > Preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of NK cells against leukemia. J Biol Chem. 2015;290:22474.

科学

Preclinical characterization of an NKp80-Fc fusion protein for redirected cytolysis of NK cells against leukemia. J Biol Chem. 2015;290:22474.

2015-07-21

分享至：

ICP备字：皖ICP备2022011087号-1 （皖）-非经营性-2022-0075 皖公网安备 34019102001077号 Copyright © 2022 合肥天港免疫药物有限公司网站技术支持：网新科技

法律声明隐私政策使用条款